Top 10 Global Pharmaceutical Company Selects etrials eClinical Software Solutions for Third Consecutive Trial
MORRISVILLE, N.C.–(BUSINESS WIRE)–etrials® Worldwide, Inc. (Nasdaq:ETWC) (Nasdaq:ETWCW) (Nasdaq:ETWCU), a leading provider of eClinical software and services that optimize clinical-trial management and accelerate time-to-market, today announced an agreement with a top ten global pharmaceutical company to develop and deploy its eDiary solutions for an upcoming clinical trial.
The Phase III clinical trial will study the effectiveness of a treatment by evaluating the occurrence of nerve pain related to Diabetes. As a leading provider of electronic patient reported outcome (ePRO) solutions, etrials will provide software to run on wireless handheld devices for more than 500 subjects in 80 sites across the U.S. and Canada. etrials’ eDiary solution, standardized on the Windows® mobile platform, is designed to help customers bring drugs to market quicker by increasing the overall accuracy and speed of data collection, management, and analysis, in addition to minimizing problems associated with paper-based collection such as patient compliance and transcription errors.
“This agreement marks our third consecutive project with this leading global pharmaceutical company, and we are proud to be their ePRO solution provider,” said John Cline, CEO of etrials. “Our eDiary provides interfaces that are simple for patients to use and provides results that are easily and quickly accessed by study investigators and sponsors via a web-based portal. As we continue to grow, we remain committed to our customers and maintaining our position as an innovative and forward-thinking leader with exceptional products and customer service.”
In addition to the use of etrials eDiaries, throughout the seven month trial, all sites will have access to etrials’ 24×7 global help desk, staffed by etrials employees.
About etrials®
etrials Worldwide, Inc. (Nasdaq: ETWC, ETWCW, ETWCU) a leading provider of eClinical software and services to pharmaceutical, biotechnology, medical device, and contract research organizations offers insight into all aspects of clinical trials, maximizing return on investment and accelerating time to market. With global operations, etrials is the only top tier solutions provider to offer electronic data capture (EDC), interactive voice response (IVR), and electronic patient diaries (eDiary) as part of an integrated software as a service (SaaS) platform or as individual solutions to optimize clinical trials. As an experienced leader, etrials has facilitated over 900 trials involving more than 400,000 patients in 60 countries and participated in 33 studies used for new drug applications.
Having partnered with over 100 clients, including 16 of the top 20 global pharmaceutical companies and top CROs, etrials is leading the way towards Adaptive Trials and integration between eClinical and electronic health records. To learn more visit us at www.etrials.com.
etrials is registered trademark in the United States of etrials Worldwide, Inc. Other marks belong to their respective owners and are used with permission.
